DOI:
10.1055/s-00033990
TH Open
LinksClose Window
References
Pincus T, Strand V, Koch G. , et al.
An index of the three core data set patient questionnaire measures distinguishes efficacy of active treatment from that of placebo as effectively as the American College of Rheumatology 20% response criteria (ACR20) or the Disease Activity Score (DAS) in a rheumatoid arthritis clinical trial.
Arthritis Rheum 2003;
48 (03) 625-630
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.